| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.13▲ | 2.12▲ | 2.12▲ | 2.13▲ | 2.43▼ |
| MA10 | 2.13▲ | 2.11▲ | 2.15▲ | 2.27▼ | 2.35▼ |
| MA20 | 2.11▲ | 2.16▲ | 2.15▲ | 2.47▼ | 2.05▲ |
| MA50 | 2.10▲ | 2.13▲ | 2.24▼ | 2.37▼ | 1.34▲ |
| MA100 | 2.17▲ | 2.26▼ | 2.38▼ | 2.01▲ | 2.00▲ |
| MA200 | 2.14▲ | 2.41▼ | 2.45▼ | 1.42▲ | 2.09▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.001▼ | 0.004▲ | -0.053▼ | -0.011▼ |
| RSI | 70.180▲ | 55.826▲ | 51.986▲ | 44.113▼ | 53.914▲ |
| STOCH | 58.333 | 36.976 | 23.414 | 17.485▼ | 43.720 |
| WILL %R | 0.000▲ | -22.857▲ | -37.209 | -72.559 | -65.734 |
| CCI | 278.025▲ | 81.796 | 12.646 | -68.110 | -52.216 |
|
Sunday, March 22, 2026 02:58 AM
In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Ibio, with a price target of $5.00. According to TipRanks, Dolezal is a 5-star analyst with an average ...
|
|
Friday, March 20, 2026 01:55 AM
Executives at iBio (NASDAQ:IBIO) outlined the scientific and strategic rationale for a myostatin/activin A bispecific antibody program that the company believes could become a next-generation therapy ...
|
|
Monday, March 16, 2026 01:51 PM
SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/03/26 | 2.19 | 2.19 | 2.18 | 2.19 | 15,384 |
| 24/03/26 | 2.20 | 2.24 | 2.04 | 2.08 | 901,915 |
| 23/03/26 | 2.28 | 2.30 | 2.15 | 2.21 | 683,672 |
| 20/03/26 | 2.07 | 2.15 | 2.0001 | 2.09 | 1,206,427 |
| 19/03/26 | 2.20 | 2.21 | 1.9801 | 2.10 | 1,200,387 |
| 18/03/26 | 2.49 | 2.498 | 2.165 | 2.19 | 615,665 |
| 17/03/26 | 2.41 | 2.49 | 2.35 | 2.46 | 301,626 |
| 16/03/26 | 2.49 | 2.5896 | 2.375 | 2.39 | 561,756 |
| 13/03/26 | 2.53 | 2.745 | 2.38 | 2.45 | 1,176,466 |
| 12/03/26 | 2.40 | 2.57 | 2.33 | 2.49 | 760,732 |
|
|
||||
|
|
||||
|
|